Company intelligence / Profile preview

Prima-Derm

Barcelona area, Catalonia, Spainprimaderm.com ↗

Ownership: Private
Development stage: Commercial

Overview

Prima-Derm is a Spanish molecular cosmetics company specializing in the development of innovative skincare products based on peptides and growth factors. Its flagship brand, Singuladerm, was the first to market an anti-wrinkle peptide with a botox-like effect. The company's approach is rooted in scientific research and focuses on active ingredients that mimic natural skin molecules to promote regeneration and health[2][7].

Therapeutic areas: Dermatology
Modalities: PeptidesGrowth factors
Industry: Non-Drug Biotech

Drug pipeline

2 assets

XPERT Collageneur Serum

Commercial

Indications: Skin aging

1 more asset in the full pipeline.

Request access →

Partnerships

Not specified; possible historical links to Lipotec group but operates independently since Lubrizol's acquisition of Lipotec[6].

Beyond the preview

Go deeper on Prima-Derm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prima-Derm.

Explore the full profile